Dose Titration Algorithm Tuning (DTAT) should supersede ‘the’ Maximum Tolerated Dose (MTD) in oncology dose-finding trials (Q60287): Difference between revisions
From MaRDI portal
Created a new Item |
Changed an Item |
||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Revision as of 15:34, 14 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose Titration Algorithm Tuning (DTAT) should supersede ‘the’ Maximum Tolerated Dose (MTD) in oncology dose-finding trials |
scientific article |
Statements
6
0 references
112
0 references
17 July 2017
0 references
